Stenman UH - Search Results

1

Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study.

Johansson M, Holmström B, Hinchliffe SR, Bergh A, Stenman UH, Hallmans G, Wiklund F, Stattin P. Johansson M, et al. Among authors: stenman uh. Int J Cancer. 2012 Jan 1;130(1):129-37. doi: 10.1002/ijc.25986. Epub 2011 Apr 1. Int J Cancer. 2012. PMID: 21328341

2

Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.

Auvinen A, Tammela T, Stenman UH, Uusi-Erkkilä I, Leinonen J, Schröder FH, Hakama M. Auvinen A, et al. Among authors: stenman uh. Br J Cancer. 1996 Aug;74(4):568-72. doi: 10.1038/bjc.1996.402. Br J Cancer. 1996. PMID: 8761371 Free PMC article. Clinical Trial.

3

European randomized study of prostate cancer screening: first-year results of the Finnish trial.

Määttänen L, Auvinen A, Stenman UH, Rannikko S, Tammela T, Aro J, Juusela H, Hakama M. Määttänen L, et al. Among authors: stenman uh. Br J Cancer. 1999 Mar;79(7-8):1210-4. doi: 10.1038/sj.bjc.6690194. Br J Cancer. 1999. PMID: 10098761 Free PMC article. Clinical Trial.

4

Prostate-specific antigen.

Stenman UH, Leinonen J, Zhang WM, Finne P. Stenman UH, et al. Semin Cancer Biol. 1999 Apr;9(2):83-93. doi: 10.1006/scbi.1998.0086. Semin Cancer Biol. 1999. PMID: 10202130 Review.

5

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R. Stattin P, et al. Among authors: stenman uh. J Natl Cancer Inst. 2000 Dec 6;92(23):1910-7. doi: 10.1093/jnci/92.23.1910. J Natl Cancer Inst. 2000. PMID: 11106682

6

Leptin is associated with increased prostate cancer risk: a nested case-referent study.

Stattin P, Söderberg S, Hallmans G, Bylund A, Kaaks R, Stenman UH, Bergh A, Olsson T. Stattin P, et al. Among authors: stenman uh. J Clin Endocrinol Metab. 2001 Mar;86(3):1341-5. doi: 10.1210/jcem.86.3.7328. J Clin Endocrinol Metab. 2001. PMID: 11238530

7

Plasma prolactin and prostate cancer risk: A prospective study.

Stattin P, Rinaldi S, Stenman UH, Riboli E, Hallmans G, Bergh A, Kaaks R. Stattin P, et al. Among authors: stenman uh. Int J Cancer. 2001 May 1;92(3):463-5. doi: 10.1002/ijc.1191. Int J Cancer. 2001. PMID: 11291087

8

Prostate cancer screening.

Stattin P, Stenman UH, Riboli E, Hallmans G, Kaaks R. Stattin P, et al. Among authors: stenman uh. Lancet. 2001 Apr 14;357(9263):1202-3. doi: 10.1016/S0140-6736(00)04344-0. Lancet. 2001. PMID: 11332426 No abstract available.

9

Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer.

Isola J, Auvinen A, Poutiainen M, Kakkola L, Järvinen TA, Määttänen L, Stenman UH, Tammela T, Hakama M, Visakorpi T. Isola J, et al. Among authors: stenman uh. J Urol. 2001 May;165(5):1569-74. J Urol. 2001. PMID: 11342919 Clinical Trial.

10

Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland.

Hakama M, Stenman UH, Aromaa A, Leinonen J, Hakulinen T, Knekt P. Hakama M, et al. Among authors: stenman uh. J Urol. 2001 Dec;166(6):2189-91; discussion 2191-2. doi: 10.1016/s0022-5347(05)65532-2. J Urol. 2001. PMID: 11696733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters